Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Functional Genomic Market Trends and Forecast
3.3: Global Genomics Market by Deliverable
3.3.1: Products
3.3.1.1: Instruments and Softwares
3.3.1.2: consumables and Reagents
3.3.2: Services
3.3.2.1: Core Genomics Services
3.3.2.2: NGS-based Services
3.3.2.3: Biomarker Translation Services
3.3.2.4: Computational Services
3.3.2.5: Others
3.4: Global Genomics Market by Technology
3.4.1: Polymerase Chain Reaction (PCR)
3.4.2: Sequencing
3.4.3: Microarray
3.4.4: Nucleic Acid Extraction and Purification
3.4.5: Other Technologies
3.5: Global Genomics Market by End User
3.5.1: Clinical and Research Laboratories
3.5.2: Academic and Government Institutes
3.5.3: Hospitals and Clinics
3.5.4: Pharmaceutical and Biotechnology Companies
3.5.5: Other End Users
4. Market Trends and Forecast Analysis by Region
4.1: Global Functional Genomic Market by Region
4.2: North American Functional Genomic Market
4.2.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.2.2: Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.2.3: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.2.4: The United States Functional Genomic Market
4.2.5: The Canadian Functional Genomic Market
4.2.6: The Mexican Functional Genomic Market
4.3: European Functional Genomic Market
4.3.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.3.2: Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.3.3: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.3.4: The Functional Genomic Market of United Kingdom
4.3.5: The German Functional Genomic Market
4.3.6: The French Functional Genomic Market
4.4: APAC Functional Genomic Market
4.4.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.4.2: Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.4.3: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.4.4: The Chinese Functional Genomic Market
4.4.5: The Indian Functional Genomic Market
4.4.6: The Japanese Functional Genomic Market
4.5: ROW Functional Genomic Market
4.5.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and Reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others)
4.5.2: Market by Technology: PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.5.3: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.5.4: Brazilian Functional Genomic Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Functional Genomic Market by Deliverable
7.1.2: Growth Opportunities for the Global Functional Genomic Market by Technology
7.1.3: Growth Opportunities for the Global Functional Genomic Market by End User
7.1.4: Growth Opportunities for the Global Functional Genomic Market by Region
7.2: Emerging Trends in the Global Functional Genomic Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Functional Genomic Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Functional Genomic Market
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: Thermo Fisher Scientific, Inc.
8.2: Agilent Technologies, Inc.
8.3: Eppendorf AG
8.4: Bio-Rad Laboratories, Inc.
8.5: Company 5
8.6: Company 6
8.7: Company 7
8.8: Company 8
8.9: Company 9
8.10: Company 10